Vir Biotechnology Inc (VIR) Company Profile & Statistics

Vir Biotechnology Inc
VIR
(Nasdaq - US)
Open
8.51
-0.06 (-0.70%)
in:usd•As of: Apr 16, 2024 11:37 UTC -4
Open
8.45
High
8.57
Low
8.35

About Vir Biotechnology Inc

CEO

Marianne De Backer

Headquarters

1800 owens street, suite 900

san francisco, ca 94158, united states

Auditor

Ernst & Young LLP

Employees

587

Share Holders

135,032,300

Website

www.vir.bio

Industry

biotechnology

Sector

health technology

Company Overview

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States.

Vir Biotechnology Inc Statistics

Valuation Measures

Market Capitalization ²	1.14B
Enterprise Value	889.75M
Enterprise Value/EBITDA (ttm)	-1.32
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.76
Price to Sales (ttm)	14.00
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	97.55%
Operating Margin (ttm)	-713.69%
Profit Margin (ttm)	-3059.15%
Return on Equity (ttm)	-34.92%
Return on Invested Capital (ttm)	-34.96%
Return on Assets (ttm)	-27.73%

Income Statement

Revenue (ttm)	86.18M
Revenue Per Share (ttm)	0.64
Gross Profit (ttm)	83.41M
EBITDA (ttm)³	-673.56M
Net Income Avi to Common (ttm)	-615.06M
Diluted EPS (ttm)	-4.59

Share Statistics

Beta (5Y Monthly)	0.41
52-Week Change	-65.99%
S&P500 52-Week Change	21.82%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	135.03M
Dividend Yield	0.00%
Float ⁴	110.16M
% Held by Insiders	18.10%
% Held by Institutions	65.32%

Balance Sheet

Total Cash (mrq)	1.54B
Total Cash Per Share (mrq)	11.37
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	9.05%
Quick Ratio (mrq)	9.05%
Book Value Per Share (mrq)	11.80

Cash Flow

Operating Cash Flow Per Share (ytd)	-5.81
Free Cash Flow (ytd)	-800.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Vir Biotechnology Inc

Trade With A Regulated Broker